HSP90AB1 and neoplasm: By binding to the N‐terminal ATP‐binding pocket of HSP90, it prevents ATP binding and hydrolysis, thereby disrupting multiple oncogenic signaling pathways, inducing tumor cell apoptosis and cell cycle arrest, and reversing drug resistance.